Core Laboratories

CLB

Market cap $603M

Overview Fund Activity

12.85 USD

+0.41

3.3%

At close Updated Sep 16, 4:00 PM EDT

Pre-market

After hours

12.85

0.00

0%

1 day

3.3%

5 days

1.02%

1 month

22.38%

3 months

6.02%

6 months

-13.7%

Year to date

-29.63%

1 year

-26.61%

5 years

-32.37%

10 years

-88.21%

About: Core Laboratories Inc provides reservoir description and production enhancement services for oil and gas exploration and production. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services.

Employees: 3,500

Energy Oil & Gas Equipment & Services

0

Funds holding %

of 7,463 funds

–

Analysts bullish %

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

17% more repeat investments, than reductions

Existing positions increased: 69 | Existing positions reduced: 59

2.67% more ownership

Funds ownership: 108.63% [Q1] → 111.31% (+2.67%) [Q2]

10% less first-time investments, than exits

New positions opened: 28 | Existing positions closed: 31

3% less funds holding

Funds holding: 195 [Q1] → 190 (-5) [Q2]

21% less capital invested

Capital invested by funds: $762M [Q1] → $601M (-$161M) [Q2]

35% less call options, than puts

Call options by funds: $500K | Put options by funds: $766K

See Fund Rankings

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target

$12

7% downside

Avg. target

$12

7% downside

High target

$12

7% downside

1 analyst rating

0 positive

0%

1 neutral

100%

0 negative

0%

Stifel

Stephen Gengaro

$12

Hold

Maintained

16 Jul 2025

See Analyst Rankings

Financial journalist opinion

Zacks Investment Research

Core Laboratories: Not a Buy Yet, But Still Worth Holding On

CLB expands globally with new tech labs and energy transition projects while reducing debt but faces tariff pressures, U.S. market softness and demand volatility risks.

Core Laboratories: Not a Buy Yet, But Still Worth Holding On

The Motley Fool

Core Labs Posts Flat Revenue in Q2

Core Laboratories (CLB 2.98%), a specialist in reservoir optimization and production enhancement services for the oil and gas industry, reported its second quarter 2025 earnings on July 23, 2025. GAAP revenue of $130.2 million for Q2 2025 outpaced analyst expectations of $129.1 million, and adjusted EPS of $0.19 matched consensus estimates.

Core Labs Posts Flat Revenue in Q2

Zacks Investment Research

Core Laboratories Q2 Earnings Beat Estimates, Expenses Increase Y/Y

CLB's second-quarter earnings beat estimates. However, it declined year over year due to the underperformance of the Reservoir Description segment.

Core Laboratories Q2 Earnings Beat Estimates, Expenses Increase Y/Y

Core Laboratories Inc. (CLB) Q2 2025 Earnings Call Transcript

Core Laboratories Inc. (NYSE:CLB ) Q2 2025 Earnings Conference Call July 24, 2025 8:30 AM ET Company Participants Christopher Scott Hill - Senior VP & CFO Gwendolyn Y. Gresham - Senior Vice President of Corporate Development & Investor Relations Lawrence V.

Core Laboratories Inc. (CLB) Q2 2025 Earnings Call Transcript

Zacks Investment Research

Core Laboratories (CLB) Beats Q2 Earnings and Revenue Estimates

Core Laboratories (CLB) came out with quarterly earnings of $0.19 per share, beating the Zacks Consensus Estimate of $0.18 per share. This compares to earnings of $0.22 per share a year ago.

Core Laboratories (CLB) Beats Q2 Earnings and Revenue Estimates

CORE LAB REPORTS SECOND QUARTER 2025 RESULTS

REVENUE OF $130.2 MILLION, UP 5% SEQUENTIALLY AND FLAT YEAR-OVER-YEAR OPERATING INCOME OF $15.3 MILLION; EX-ITEMS, $14.5 MILLION, UP OVER 23% SEQUENTIALLY AND DOWN 11% YEAR-OVER-YEAR OPERATING MARGINS, EX-ITEMS, OF 11%, EXPANDED 160 BASIS POINTS SEQUENTIALLY, WITH INCREMENTAL MARGINS, EX-ITEMS, OF 41% GAAP EPS OF $0.22; EX-ITEMS, $0.19, UP 33% SEQUENTIALLY, AND DOWN 14% YEAR-OVER-YEAR COMPANY REPURCHASED 237,632 SHARES OF COMMON STOCK, A VALUE OF $2.7 MILLION FREE CASH FLOW OF $10.4 MILLION, UP OVER 160% SEQUENTIALLY NET DEBT REDUCED BY $9.1 MILLION; DEBT LEVERAGE RATIO IMPROVED TO 1.27 COMPANY ANNOUNCES Q2 2025 QUARTERLY DIVIDEND HOUSTON , July 23, 2025 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") reported second quarter 2025 revenue of $130,200,000. Core's operating income was $15,300,000, with earnings per diluted share ("EPS") of $0.22, all in accordance with U.S. generally accepted accounting principles ("GAAP").

CORE LAB REPORTS SECOND QUARTER 2025 RESULTS

Zacks Investment Research

Watch These 4 Energy Stocks for Q2 Earnings: Beat or Miss?

Here's a preview of what to expect from energy stocks EQNR, CLB, OII and PTEN ahead of their quarterly earnings reports, set to be released tomorrow.

Watch These 4 Energy Stocks for Q2 Earnings: Beat or Miss?

Zacks Investment Research

Core Laboratories to Post Q2 Earnings: Key Metrics to Watch

CLB's second-quarter revenues are likely to have declined from the year-ago period's level due to weak segment revenues.

Core Laboratories to Post Q2 Earnings: Key Metrics to Watch

Zacks Investment Research

Core Lab Stock Plunges 22% in Six Months: Time to Hold or Sell?

CLB struggles with declining revenues, geopolitical risks, margin compression and weak U.S. demand, creating uncertainty around growth and profitability prospects.

Core Lab Stock Plunges 22% in Six Months: Time to Hold or Sell?

Core Laboratories: Better Without Its Non-Core?

Core Laboratories trades near five-year lows but suffers from limited investor interest and unclear financial segment breakdowns, despite global diversification and energy transition exposure. Reservoir Description is the standout segment, offering recurring, high-margin services with long-term demand, especially as energy transition projects like CCS gain traction. Production Enhancement faces high competition and low margins, and the company's lack of transparency and communication limits investor confidence and potential re-rating.

Core Laboratories: Better Without Its Non-Core?

See News Rankings

Charts implemented using Lightweight Charts™